These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 23278641)
1. Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis. Quintás-Cardama A; Sever M; Cortes J; Kantarjian H; Verstovsek S Leuk Lymphoma; 2013 Sep; 54(9):1959-64. PubMed ID: 23278641 [TBL] [Abstract][Full Text] [Related]
2. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis. Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486 [TBL] [Abstract][Full Text] [Related]
3. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis. Carter MC; Clayton ST; Komarow HD; Brittain EH; Scott LM; Cantave D; Gaskins DM; Maric I; Metcalfe DD J Allergy Clin Immunol; 2015 Dec; 136(6):1673-1679.e3. PubMed ID: 26044856 [TBL] [Abstract][Full Text] [Related]
4. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914 [TBL] [Abstract][Full Text] [Related]
5. [Tryptase: A practical guide for the physician]. Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S Rev Med Interne; 2020 Nov; 41(11):748-755. PubMed ID: 32712042 [TBL] [Abstract][Full Text] [Related]
6. Mastocytosis: state of the art. Horny HP; Sotlar K; Valent P Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883 [TBL] [Abstract][Full Text] [Related]
7. Hypertryptasemia and Mast Cell-Related Disorders in Severe Osteoporotic Patients. Carosi G; Guabello G; Longhi M; Grifoni F; Passeri E; Corbetta S Mediators Inflamm; 2020; 2020():5785378. PubMed ID: 33144848 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis. Bulai Livideanu C; Apoil PA; Lepage B; Eischen M; Laurent C; Laharrague P; Lamant L; Tournier E; Tavitian S; Pouplard C; Recher C; Laroche M; Mailhol C; Dubreuil P; Hermine O; Blancher A; Paul C Clin Exp Allergy; 2016 Jan; 46(1):133-41. PubMed ID: 26767494 [TBL] [Abstract][Full Text] [Related]
9. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management. Pardanani A Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340 [TBL] [Abstract][Full Text] [Related]
10. Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis. Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB; Eur J Haematol; 2013 Aug; 91(2):106-11. PubMed ID: 23621866 [TBL] [Abstract][Full Text] [Related]
11. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology. Giannetti MP; Akin C; Hufdhi R; Hamilton MJ; Weller E; van Anrooij B; Lyons JJ; Hornick JL; Pinkus G; Castells M; Pozdnyakova O J Allergy Clin Immunol; 2021 Apr; 147(4):1497-1501.e1. PubMed ID: 33248113 [TBL] [Abstract][Full Text] [Related]
12. Mast Cell Burden in a Patient With Cutaneous Disease. Awosika O; Eleryan M; Rengifo-Pardo M; Ehrlich A J Drugs Dermatol; 2017 Dec; 16(12):1285-1287. PubMed ID: 29240865 [TBL] [Abstract][Full Text] [Related]
13. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management. Pardanani A Am J Hematol; 2015 Mar; 90(3):250-62. PubMed ID: 25688753 [TBL] [Abstract][Full Text] [Related]
14. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205 [TBL] [Abstract][Full Text] [Related]
15. Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow. Johnson MR; Verstovsek S; Jorgensen JL; Manshouri T; Luthra R; Jones DM; Bueso-Ramos CE; Medeiros LJ; Huh YO Mod Pathol; 2009 Jan; 22(1):50-7. PubMed ID: 19116630 [TBL] [Abstract][Full Text] [Related]
16. Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects. Vos BJ; van der Veer E; van Voorst Vader PC; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; de Monchy JG; van Doormaal JJ; Oude Elberink JN J Allergy Clin Immunol; 2015 Mar; 135(3):792-8. PubMed ID: 25129675 [TBL] [Abstract][Full Text] [Related]
17. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis. Berezowska S; Flaig MJ; Ruëff F; Walz C; Haferlach T; Krokowski M; Kerler R; Petat-Dutter K; Horny HP; Sotlar K Mod Pathol; 2014 Jan; 27(1):19-29. PubMed ID: 23807778 [TBL] [Abstract][Full Text] [Related]
18. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders. Divekar R; Butterfield J Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439 [TBL] [Abstract][Full Text] [Related]